na Venture Capital
<UNKNOWN>, KR · 1 known investors
NAV Vaccine develops preventive and therapeutic drugs using immune system technology. The company focuses on cancer treatments, immunotherapy combination therapies, viral prevention vaccines, and tissue regeneration therapeutics.
BiotechHealthtechMedical Devices